William E. Russell, MD
Harvard Medical School, Boston, MA
Pediatric Residency-Massachusetts General Hospital, Boston, MA
Clinical and Research Children's Service Fellowship-Massachusetts General Hospital and Shiners' Burns Institute, Boston, MA
Pediatric Endocrinology Fellowship-University of North Carolina, Chapel Hill, NC
Diabetes, growth, puberty, thyroid, adrenal, disorders of sex development (DSD)
Dr. Russell studies ways to predict and to prevent type 1 diabetes (T1) He is the Principal Investigator at Vanderbilt for the Type 1 Diabetes TrialNet consortium, which is funded by the National Institutes of Health prevent type 1 diabetes in people at risk and to preserve insulin secretion in those who have T1D. He leads the international abatacept trial (TN18) to determine an immune system modulating drug (CTLA4-Ig) can prevent the development of T1D in people at high risk to progress to full-blown T1D.